Ampio Pharmaceuticals, Inc. - FORM 10-Q - EX-32.1 - SECTION 906 CEO AND CFO CERTIFICATION - August 16, 2010

Attached files

file filename
10-Q - FORM 10-Q - Ampio Pharmaceuticals, Inc.d10q.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - Ampio Pharmaceuticals, Inc.dex312.htm
EX-99.1 - PRESS RELEASE BY AMPIO PHARMACEUTICALS, INC - Ampio Pharmaceuticals, Inc.dex991.htm
EX-10.1 - NOTES PAYABLE DATED JUNE 23, 2010 - Ampio Pharmaceuticals, Inc.dex101.htm
EX-99.3 - CORRECTION TO PRESS RELEASE BY AMPIO PHARMACEUTICALS, INC - Ampio Pharmaceuticals, Inc.dex993.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - Ampio Pharmaceuticals, Inc.dex311.htm
EX-99.2 - PRESS RELEASE BY AMPIO PHARMACEUTICALS, INC - Ampio Pharmaceuticals, Inc.dex992.htm

Exhibit 32.1

AMPIO PHARMACEUTICALS, INC. AND SUBSIDIARIES

Certification Pursuant to 18 U.S.C. Section 1350, as Adopted

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the filing of the quarterly report on Form 10-Q for the quarter ended June 30, 2010 (the “Report”) by Ampio Pharmaceuticals, Inc. (the “Company”), each of the undersigned hereby certifies that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: August 16, 2010      

/S/    DONALD B. WINGERTER, JR.          

     

Donald B. Wingerter, Jr.

Chief Executive Officer

Dated: August 16, 2010      

/S/    BRUCE G. MILLER        

     

Bruce G. Miller

Chief Financial Officer

Ampio Pharmaceuticals, Inc. Reports